| Objective: To explore the mechanism of parthenolide in inhibiting HER-2 positive breast cancer cell line SK-BR-3.Methods:(1)The in vitro survival ability of HER-2 positive breast cancer cell line SK-BR3 treated with different concentrations of parthenolide was observed by CCK-8 assay,and the IC50 value of parthenolide was calculated.(2)EDU staining and colony formation assay were used to further observe the proliferation ability of SK-BR-3cells under the intervention of altered concentrations of parthenolide.(3)Flow cytometry was utilized to detect the changes of apoptosis and cell cycle of SK-BR-3 cells treated with parthenolide.(4)Western blot method was utilized to observe the changes of protein expression of Src,p-Src,Cdh1,STAT3,p-STAT3 and PD-L1 in breast cancer cells SK-BR-3treated with parthenolide.Results:(1)Parthenolide could inhibit the viability of breast cancer cell line SK-BR-3 in vitro.CCK-8 results showed that the viability of SK-BR-3 cells decreased significantly with the increase of concentration,and the IC50 value was 7.27μmol/L.(2)EDU staining and colony formation assay showed that the proliferation activity of SK-BR-3 cells decreased with the increase of parthenolide concentration.(3)Parthenolide could induce apoptosis of SK-BR-3 cells in vitro.The results of flow cytometry showed that different concentrations of parthenolide(5μmol/L,10μmol/L,15μmol/L)could induce apoptosis of SK-BR-3 cells,and the apoptosis rate increased with the increase of parthenolide concentration.(4)Parthenolide interferes with the cell cycle progression of SK-BR-3 by blocking S phase.(5)Parthenolide can down-regulate PD-L1 expression by regulating Src signal pathway,suggesting that the inhibitory mechanism of parthenolide on SK-BR-3cells may be linked to the regulation of Src/PD-L1.Conclusion: Parthenolide can significantly inhibit the proliferation of HER-2 positive breast cancer cell line SK-BR-3 and promote its apoptosis in vitro.The mechanism of action may be closely linked to the regulation of Src/PD-L1. |